These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 37630545)
41. A Serological Analysis of the Humoral Immune Responses of Anti-RBD IgG, Anti-S1 IgG, and Anti-S2 IgG Levels Correlated to Anti-N IgG Positivity and Negativity in Sicilian Healthcare Workers (HCWs) with Third Doses of the mRNA-Based SARS-CoV-2 Vaccine: A Retrospective Cohort Study. Serra N; Andriolo M; Butera I; Mazzola G; Sergi CM; Fasciana TMA; Giammanco A; Gagliano MC; Cascio A; Di Carlo P Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514952 [TBL] [Abstract][Full Text] [Related]
43. Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutralization assay. Resman Rus K; Korva M; Knap N; Avšič Županc T; Poljak M J Clin Virol; 2021 Jun; 139():104820. PubMed ID: 33865031 [TBL] [Abstract][Full Text] [Related]
44. Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants. Chen CP; Huang KA; Shih SR; Lin YC; Cheng CY; Huang YC; Lin TY; Cheng SH Microbiol Spectr; 2022 Aug; 10(4):e0074322. PubMed ID: 35703556 [TBL] [Abstract][Full Text] [Related]
45. Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients. Fujigaki H; Inaba M; Osawa M; Moriyama S; Takahashi Y; Suzuki T; Yamase K; Yoshida Y; Yagura Y; Oyamada T; Takemura M; Doi Y; Saito K J Immunol; 2021 May; 206(10):2393-2401. PubMed ID: 33941657 [TBL] [Abstract][Full Text] [Related]
46. Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays. Ismail A; Shurrab FM; Al-Jighefee HT; Al-Sadeq DW; Qotba H; Al-Shaar IA; Yassine HM; Abu-Raddad LJ; Nasrallah GK Front Biosci (Landmark Ed); 2021 Jul; 26(7):198-206. PubMed ID: 34340267 [No Abstract] [Full Text] [Related]
47. A Multiplex Microsphere IgG Assay for SARS-CoV-2 Using ACE2-Mediated Inhibition as a Surrogate for Neutralization. Cameron A; Porterfield CA; Byron LD; Wang J; Pearson Z; Bohrhunter JL; Cardillo AB; Ryan-Muntz L; Sorensen RA; Caserta MT; Angeloni S; Hardy DJ; Zand MS; Pecora ND J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139422 [TBL] [Abstract][Full Text] [Related]
48. Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays. Dou X; Wang E; Jiang R; Li M; Xiong D; Sun B; Zhang X Immun Inflamm Dis; 2022 Jun; 10(6):e612. PubMed ID: 35634960 [TBL] [Abstract][Full Text] [Related]
49. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients. Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082 [TBL] [Abstract][Full Text] [Related]